# KaliVir Immunotherapeutics, Inc. **Source:** https://www.startuphub.ai/startups/kalivir-immunotherapeutics **Profile type:** Startup > Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment. ## About KaliVir Immunotherapeutics is a clinical-stage biotechnology company focused on developing innovative, multi-mechanistic oncolytic immunotherapy programs. The company leverages its proprietary Vaccinia Enhanced Template (VET™) platform to engineer vaccinia viruses that selectively replicate in and kill cancer cells, while also stimulating anti-tumor immunity and modifying the tumor microenvironment. Their product candidates are designed for systemic intravenous delivery to treat various cancer types. ## Key facts - **Slug:** kalivir-immunotherapeutics - **Website:** https://kalivir.com/ - **Location:** Pittsburgh, United States - **Founded:** 2019-01-01 - **Employees:** 29 - **Operating status:** Active - **Total funding:** $14M - **Sectors / tags:** Biotechnology, Health, Pharmaceuticals, Oncology, Biotech, MedTech, Immunology, Drug Discovery, Clinical Trials, Gene Therapy, Oncolytic Viruses, Immunotherapy, Life Sciences - **Social:** - LinkedIn: https://www.linkedin.com/company/kalivir-immunotherapeutics/ - Twitter: https://twitter.com/KaliVirImmuno ## Frequently asked ### What does KaliVir Immunotherapeutics, Inc. do? KaliVir Immunotherapeutics is a clinical-stage biotechnology company focused on developing innovative, multi-mechanistic oncolytic immunotherapy programs. The company leverages its proprietary Vaccinia Enhanced Template (VET™) platform to engineer vaccinia viruses that selectively replicate in and kill cancer cells, while also stimulating anti-tumor immunity and modifying the tumor microenvironment. Their product candidates are designed for systemic intravenous delivery to treat various cancer t… ### What is KaliVir Immunotherapeutics, Inc.'s Effective Domain Rating? StartupHub's Effective Domain Rating for KaliVir Immunotherapeutics, Inc. is 9 out of 100, measuring real cross-surface visibility in search engines and AI answers rather than claimed link authority. That is fairly rated against its Ahrefs Domain Rating of 10. ### Is KaliVir Immunotherapeutics, Inc. trustworthy and reputable? StartupHub's Data Trust & Reputation score for KaliVir Immunotherapeutics, Inc. is 52 out of 100, based on site security posture and privacy practices. ### What is KaliVir Immunotherapeutics, Inc.'s revenue? StartupHub estimates KaliVir Immunotherapeutics, Inc.'s annual revenue at $3.3M (range $2.0M to $11.4M, 67% confidence), based on comparable companies in the sector. ### What is KaliVir Immunotherapeutics, Inc.'s valuation? StartupHub estimates KaliVir Immunotherapeutics, Inc.'s effective valuation at $977.2M (range $684.1M to $1.3B, 42% confidence), based on comparable companies in the sector. ### How much funding has KaliVir Immunotherapeutics, Inc. raised? KaliVir Immunotherapeutics, Inc. has raised a total of $14M in funding. The most recent round on record is Series A Extension. ### Where is KaliVir Immunotherapeutics, Inc. headquartered? KaliVir Immunotherapeutics, Inc. is headquartered in Pittsburgh, United States. ### When was KaliVir Immunotherapeutics, Inc. founded? KaliVir Immunotherapeutics, Inc. was founded in 2019. ### What industry does KaliVir Immunotherapeutics, Inc. operate in? KaliVir Immunotherapeutics, Inc. operates in Biotechnology, Health, Pharmaceuticals, Oncology, Biotech, MedTech. ### How many employees does KaliVir Immunotherapeutics, Inc. have? KaliVir Immunotherapeutics, Inc. has approximately 29 people on record. ## JSON-LD Structured data aligned with this page's `